Thomas E. Raya

951 total citations
17 papers, 752 citations indexed

About

Thomas E. Raya is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Thomas E. Raya has authored 17 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 3 papers in Molecular Biology and 3 papers in Physiology. Recurrent topics in Thomas E. Raya's work include Cardiovascular Function and Risk Factors (7 papers), Heart Failure Treatment and Management (5 papers) and Cardiac Fibrosis and Remodeling (4 papers). Thomas E. Raya is often cited by papers focused on Cardiovascular Function and Risk Factors (7 papers), Heart Failure Treatment and Management (5 papers) and Cardiac Fibrosis and Remodeling (4 papers). Thomas E. Raya collaborates with scholars based in United States and Australia. Thomas E. Raya's co-authors include Steven Goldman, Eugene Morkin, Mohamed A. Gaballa, Gregory D. Pennock, Jia Liu, B. R. Simon, James J. Milavetz, Peter G. Anderson, Cynthia S. Johnson and Kenneth W. Mahaffey and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Hypertension.

In The Last Decade

Thomas E. Raya

17 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas E. Raya United States 13 537 189 110 94 91 17 752
T E Raya United States 15 636 1.2× 201 1.1× 131 1.2× 144 1.5× 106 1.2× 20 859
S E Litwin United States 10 807 1.5× 211 1.1× 117 1.1× 188 2.0× 89 1.0× 12 981
Janice M. Pfeffer United States 16 636 1.2× 192 1.0× 49 0.4× 104 1.1× 76 0.8× 32 785
Omar Nass United States 7 680 1.3× 250 1.3× 177 1.6× 75 0.8× 53 0.6× 10 796
O BING United States 13 527 1.0× 216 1.1× 36 0.3× 98 1.0× 97 1.1× 22 714
Masaki Shimoyama Japan 16 506 0.9× 513 2.7× 57 0.5× 117 1.2× 67 0.7× 30 856
Teruhiko Aoyagi Japan 16 441 0.8× 380 2.0× 164 1.5× 190 2.0× 93 1.0× 45 869
Takao Nishizawa Japan 16 487 0.9× 166 0.9× 70 0.6× 93 1.0× 162 1.8× 28 774
Yoko Eto Japan 10 281 0.5× 248 1.3× 101 0.9× 67 0.7× 61 0.7× 20 557
Eric E. Morgan United States 17 339 0.6× 359 1.9× 99 0.9× 69 0.7× 189 2.1× 31 797

Countries citing papers authored by Thomas E. Raya

Since Specialization
Citations

This map shows the geographic impact of Thomas E. Raya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Raya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Raya more than expected).

Fields of papers citing papers by Thomas E. Raya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Raya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Raya. The network helps show where Thomas E. Raya may publish in the future.

Co-authorship network of co-authors of Thomas E. Raya

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Raya. A scholar is included among the top collaborators of Thomas E. Raya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Raya. Thomas E. Raya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Baran, Kenneth W., et al.. (2010). Very Rapid Treatment of ST-Segment–Elevation Myocardial Infarction. Circulation Cardiovascular Quality and Outcomes. 3(4). 431–437. 17 indexed citations
2.
Thai, Hoang & Thomas E. Raya. (1999). Angiotensin II receptor blockers. Coronary Artery Disease. 10(6). 377–382. 3 indexed citations
3.
Gaballa, Mohamed A., et al.. (1999). Effects of AT1 receptor blockade after myocardial infarct on myocardial fibrosis, stiffness, and contractility. American Journal of Physiology-Heart and Circulatory Physiology. 276(3). H873–H880. 38 indexed citations
4.
Gaballa, Mohamed A., et al.. (1998). Large Artery Remodeling During Aging. Hypertension. 32(3). 437–443. 135 indexed citations
5.
Raya, Thomas E., Mohamed A. Gaballa, Peter G. Anderson, & Steven Goldman. (1997). Left ventricular function and remodeling after myocardial infarction in aging rats. American Journal of Physiology-Heart and Circulatory Physiology. 273(6). H2652–H2658. 69 indexed citations
6.
Milavetz, James J., Thomas E. Raya, Cynthia S. Johnson, Eugene Morkin, & Steven Goldman. (1996). Survival after myocardial infarction in rats: captopril versus losartan. Journal of the American College of Cardiology. 27(3). 714–719. 82 indexed citations
7.
Gaballa, Mohamed A., et al.. (1996). Relative Contribution of Angiotensin II, Bradykinin, and Prostaglandins to the Renal Effects of Converting Enzyme Inhibition in Rats After Chronic Myocardial Infarction. Journal of Cardiovascular Pharmacology. 28(1). 167–174. 5 indexed citations
8.
Morkin, Eugene, Gregory D. Pennock, Thomas E. Raya, Joseph J. Bahl, & Steven Goldman. (1996). Development of a Thyroid Hormone Analogue for the Treatment of Congestive Heart Failure. Thyroid. 6(5). 521–526. 16 indexed citations
9.
Milavetz, James J., et al.. (1995). 965-46 Survival After Large Myocardial Infarction in Rats: Comparison of ACE Inhibition with Captopril Versus Direct Angiotensin II Blockade with Losartan. Journal of the American College of Cardiology. 25(2). 221A–221A. 1 indexed citations
10.
Goldman, Steven & Thomas E. Raya. (1995). Rat infarct model of myocardial infarction and heart failure. Journal of Cardiac Failure. 1(2). 169–177. 80 indexed citations
11.
Mahaffey, Kenneth W., Thomas E. Raya, Gregory D. Pennock, Eugene Morkin, & Steven Goldman. (1995). Left Ventricular Performance and Remodeling in Rabbits After Myocardial Infarction. Circulation. 91(3). 794–801. 82 indexed citations
12.
Morkin, Eugene, Gregory D. Pennock, Thomas E. Raya, Joseph J. Bahl, & Steven Goldman. (1993). Studies on the use of thyroid hormone and a thyroid hormone analogue in the treatment of congestive heart failure. The Annals of Thoracic Surgery. 56(1). S54–S60. 21 indexed citations
13.
Raya, Thomas E., et al.. (1991). Effects of captopril on the beta-adrenergic system in noninfarcted myocardium in the rat heart failure model. Journal of the American College of Cardiology. 17(2). A133–A133. 1 indexed citations
14.
Litwin, Sheldon E., et al.. (1991). Effects of captopril on contractility after myocardial infarction: Experimental observations. The American Journal of Cardiology. 68(14). 26–34. 14 indexed citations
15.
Raya, Thomas E., Richard Lee, Steven Goldman, et al.. (1991). Hemodynamic Effects of Direct Angiotensin II Blockade Compared to Converting Enzyme Inhibition in Rat Model of Heart Failure. American Journal of Hypertension. 4(4_Pt_2). 334S–340S. 81 indexed citations
16.
Bedotto, John B., Paul Grayburn, William H. Black, et al.. (1990). Alterations in left ventricular relaxation during atrioventricular pacing in humans. Journal of the American College of Cardiology. 15(3). 658–664. 85 indexed citations
17.
Gay, Richard G., Thomas E. Raya, & Steven Goldman. (1990). Chronic Propranolol Treatment Promotes Left Ventricular Dilation Without Altering Systolic Function After Large Myocardial Infarction in Rats. Journal of Cardiovascular Pharmacology. 16(4). 529–536. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026